chadox1 mers
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 14, 2018 (NCT03399578)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Middle East respiratory syndrome-related coronavirusImmunity, active
Middle East respiratory syndrome-related coronavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04170829 | Phase 1 | Jan 1, 2020 | King Abdullah Medical City, National Guard Health Affairs, University of Oxford |
| NCT03399578 | Phase 1 | Mar 14, 2018 | University of Oxford |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Oxford | Academic/Hospital | 2 | 1 | 1 | 2018 |
| King Abdullah Medical City | Academic/Hospital | 1 | 1 | 1 | 2020 |
| National Guard Health Affairs | Academic/Hospital | 1 | 0 | 1 | 2020 |
3 organizations
Page 1 / 1